Bukwang Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
25,583
29,600
31,840
21,032
14,883
191,056
Depreciation, Depletion & Amortization
7,632
5,676
5,127
5,698
6,100
6,876
Other Funds
7,092
6,036
10,671
22,962
6,286
159,420
Funds from Operations
26,124
29,240
26,295
3,768
14,697
38,511
Changes in Working Capital
10,391
1,377
15,998
11,531
6,134
31,695
Net Operating Cash Flow
36,515
27,863
10,298
7,763
8,563
6,817
Capital Expenditures
4,435
3,279
4,684
5,931
6,528
Sale of Fixed Assets & Businesses
1,021
119
3,963
414
298
Purchase/Sale of Investments
801
2,657
4,636
9,117
1,218
Net Investing Cash Flow
25,747
3,737
3,914
3,591
7,447
Cash Dividends Paid - Total
13,427
14,097
14,800
22,813
17,942
Issuance/Reduction of Debt, Net
20,000
-
-
-
-
Net Financing Cash Flow
33,476
14,145
14,338
22,254
18,023
Net Change in Cash
28,785
9,981
127
26,437
16,915
Free Cash Flow
32,771
24,897
5,719
11,475
4,077
Net Assets from Acquisitions
-
3,368
-
9
-
Other Sources
29,961
134
-
-
-
Change in Capital Stock
49
48
462
559
80
Exchange Rate Effect
-
-
1
11
7
About Bukwang Pharmaceutical Co.
View Profile
